CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses GLDG Q1 2026 Earnings NarrowerthanExpected Loss Reflects Steady Exploration Advances Moderna Inc MRNA Q1 2026 Earnings Narrowerthanexpected loss as cost controls offset revenue headwinds RIVN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline ETR Q1 2026 Earnings EPS Slightly Misses Estimates Amid Operational Challenges HDB Q1 FY2026 Earnings EPS Surpasses Estimates by 073 RPT Q1 2026 Earnings Significant EPS Miss Amid Challenging Real Estate Market SANUWAVE Health SNWV Q1 2026 Earnings EPS Falls Short as Revenue Remains Undisclosed DRTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Challenges Tenaya Therapeutics Q1 2026 Earnings Narrow Miss on Earnings as Biotech Firm Reports No Revenue Newmark Group NMRK Q1 2026 Earnings EPS Surges Past Estimates with 18 Beat LCTX Q1 2026 Earnings EPS Misses Estimates as Company Advances Cell Therapy Pipeline